Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBITDA MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginReturn on AssetsReturn on EquityReturn on Sales

Summit Therapeutics (SMMT) Asset Utilization Ratio (2022 - 2025)

Summit Therapeutics (SMMT) has disclosed Asset Utilization Ratio for 2 consecutive years, with 0.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 99.79% year-over-year to 0.0, compared with a TTM value of 0.0 through Sep 2025, up 99.79%, and an annual FY2022 reading of 0.0, down 89.18% over the prior year.
  • Asset Utilization Ratio was 0.0 for Q3 2025 at Summit Therapeutics, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.0 in Q2 2025 and bottomed at 0.02 in Q2 2024.